References

  1. Greenspan John, Barr Charles, Scuibba James, Winker James. Oral manifestations of HIV infection: definitions, diagnostic criteria, and principles of therapy. Oral surg Oral Med Oral Path. 1992; 73(2): 142-144. PubMed | Google Scholar

  2. Kamino Hideko, Naidoo Sudeshni. Oral HIV lesions and oral health behaviour of HIV-positive patients attending the queen Elizabeth II hospital. SADJ. 2002; 57(11): 479-82. PubMed | Google Scholar

  3. Aquirre Jose, Echebarria Maria, Ocina Esther, Ribacoba Laureano, Montejo Miguel. Reduction of HIV-associated oral lesions after highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1991; 88(2): 114-115. PubMed | Google Scholar

  4. Tappuni Anwar, Flemming Garry. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92(6): 623-628. PubMed | Google Scholar

  5. Ceballos-Salobrena Alejandro, Gaitan-Cepeda Louis, Ceballos-Garcia Laura, Lezama-Del Valle David. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS. AIDS Patient care STDS. 2000; 14(12): 627-635. PubMed | Google Scholar

  6. Septowitz Kent. Effect of HAART on natural history of AIDS-related opportunistic disorders. Lancet. 1998 Jan 24; 351(9098): 228-30. PubMed | Google Scholar

  7. Eweka Olutola, Agbelusi Gbemisola, Odukoya Onatolu. Prevalence of oral lesions and the effects of HAART in adult patients attending a tertiary hospital in Lagos, Nigeria. OJST. 2012; 2(3): 200-205. Google Scholar

  8. Cauda Roberto, Tacconelli Evelina, Tumbarelo Mario, Morace Giulia, De Bernadis Flavia et al. Role of protesae inhibitor in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. JAIDS. 1999; 21(1): 20-25. PubMed | Google Scholar

  9. Schmidt-Westhausen Andrea, Priepke Frank, Bergman Frank, Reichart Peter. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med. 2000; 29(7): 336-341. PubMed | Google Scholar

  10. Patton Lauren, McKaig Rosemary, Strauss Ronald, Rogers Dawn, Eron Joseph. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 89(3): 299-304. PubMed | Google Scholar

  11. Green wood Ian, Zakrzewska Joana, Robinson Peter. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years. Oral Dis. 2002; 8(2): 90-94. PubMed | Google Scholar

  12. Greenspan Deborah, Komaroff Eugene, Redford Maryann, Phelan Joan, Navazesh Mahvash, Alves ME, Kamrath Heidi et al. Oral mucosal lesions and HIV viral load in women's interagency HIV study (WIHS). JAIDS. 2001; 27(1): 96-97. Google Scholar

  13. Fauci Anthony, Bartlett John, Goosby Eric, Smith MD, Kaiser HJ, Chang SW et al. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Ann Intern Med. 1998; 128(12 Pt 2): 1079-1100. PubMed | Google Scholar

  14. Mocroft Amanda, Vella Stefano, Benfield Thomas. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet. 1998 Nov 28; 352(9142): 1725-30. PubMed | Google Scholar

  15. Palella Frank, Delaney Kathleen, Moorman Anne, Loveless Mark, Fuhrer Jack, Satten Glen, Aschman Diane, Holmberg Scott. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998; 338(13): 853-860. PubMed | Google Scholar

  16. Ramírez-Amador Velia, Esquivel-Pedraza Lilly, Sierra-Madero Juan, Anaya-Saavedra Gabriela, Gonzalez-Ramírez Imelde, Ponce-de-Leon Sergio. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients: a 12-year study in a referral center in Mexico. Medicine. 2003; 82(1): 39-50. PubMed | Google Scholar

  17. Morgan Dilys, Mahe Cedric, Mayanja Billy, Okongo Martin, Lubega Rosemary, Whitworth James. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries. AIDS. 2002; 16(4): 597-603. PubMed | Google Scholar

  18. EC Clearinghouse. On oral problems related to HIV infection and WHO Collaboration Center on Oral Manifestations of the immunodeficiency Virus; Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med. 1993; 22(7): 289-291. PubMed

  19. Hodgson Tim, Greenspan Deborah, Greenspan John. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res. 2006; 19(1): 57-62. PubMed | Google Scholar

  20. Feller Liviu, Chandran Rakesh, Kramer Beverley, Khammissa Razia, Altini Mario, Lemmer Johan. Melanocyte biology and function with reference to oral melanin hyperpigmentation in HIV-seropositive subjects. AIDS research and human retroviruses. 2014; 30(9): 837-843. PubMed | Google Scholar

  21. Hamza Omar, Matee Mecky, Simon Elison, Kikwilu Emil, Moshi Mainen, Mugusi Fredinand et al. "Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [CART] in Dar es Salaam, Tanzania". BMC Oral Health. 2006; 6: 12. Google Scholar

  22. Bravo Ines Maria, Correnti Maria, EscalonaLaura, Perrone Marianella, Brito Aubert, Tovar Vilma et al. "Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population,". Medicina Oral, Patología Oral y Cirugía Buca. 2006; 11(1): E33-E39. PubMed | Google Scholar

  23. Sreeja Nair, Ramakrishnan Kuppamuthu, Vijayalakshmi D et al. Oral pigmentation: a review. J Pharm Bioallied Sci. 2015; 7(Suppl 2): S403-S408. PubMed | Google Scholar

  24. McNicholl Ian. Adverse Effects of Antiretroviral Drugs. HIV Insite. 2012.

  25. Hegde Vijaya, Shetty Pooja, Alva Shubhan, Chengappa Kavery. Assessment of dental caries experience, periodontal status, and oral mucosal lesions among human immunodeficiency virus seropositives with and without antiretroviral therapy: a cross-sectional study. J Indian Assoc Public Health Dent. 2016; 14(1): 46-49. Google Scholar

  26. Saima Qadir, Nadia Naseem, Nagi Abdul. Oral Mucosal Changes in Patients of HIV/AIDS Taking Antiretroviral Therapy in Pakistan. Cytol Histol. 2014; S4: 019. Google Scholar

  27. Ponnam Srinivas, Srivastava Guatam, Theruru Kotaih. Oral manifestations of human immunodeficiency virus in children: an institutional study at highly active antiretroviral therapy centre in India. J Oral Maxillofac Pathol. 2012; 16(2): 195-202. PubMed | Google Scholar

  28. Chandran Rakesh, Khammissa Razia, Lemmer Johan, Feller Liviu. HIV associated oral melanin hyperpigmentation. SADJ. 2014; 69(8): 370-37. Google Scholar